Bank of America’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-78,400
Closed -$7.17M 8124
2021
Q2
$7.17M Buy
+78,400
New +$6.23M ﹤0.01% 3171

Other funds holding CDNA

Bank of America's CDNA Position: Q1 2026 in Review

Bank of America increased its CareDx (CDNA) stake by 45% in Q1 2026, buying an estimated $2.76M and bringing the position to 470,665 shares worth $8.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Bank of America first reported a position in CDNA in Q2 2016 and has held it in 36 quarters since. The position peaked at $15.6M in Q2 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Bank of America held 470,665 shares of CareDx worth $8.17M as of Q1 2026.
  • Bank of America bought 145,840 CareDx shares in Q1 2026, an estimated $2.76M.
  • CareDx made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3106 holding.
  • Bank of America first reported a position in CareDx in Q2 2016 and has held it in 36 quarters since.
  • Bank of America's CareDx position peaked at $15.6M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.